top of page

Eyes on Pharma
Check-out What Intel Caught our Eye


Quarterly Results, Biogen & Conference Planning
The PharmaTell Team has been busy curating Quarterly Results reports & upcoming conference planners + keeping up with Biogen next steps.

Robin Bateman
May 8, 20222 min read


AACR Updates & CAR-T Overview
This week the team has been enjoying the spring holidays and keeping their eyes on some of the recent news from AACR and learning a bit more

Robin Bateman
Apr 20, 20222 min read


PharmaTell Studio Upgrades
We are excited to share the latest upgrades to PharmaTell Studio making it even easier for you to keep your eyes on you & your competition.
jroele
Apr 4, 20222 min read


FDA Approvals, Transcripts & Conferences
This week, the team has been looking at congress planners, earnings call transcripts, and the US FDA.

Robin Bateman
Mar 27, 20222 min read


Gene Therapy Guidance
This week, the team had Eyes on the new draft guidance from the US FDA on Gene Therapy Products Incorporating Genome Editing.

Robin Bateman
Mar 20, 20222 min read


Industry Intel
Today we’ll share some of the types of reports available that can help you keep your Eyes on Pharma Sectors.

Robin Bateman
Mar 13, 20221 min read


Tracking Data
We found several different types of intel so we thought we would share some with you – and tips on how to find it.

Robin Bateman
Mar 6, 20222 min read


Opioids, SPACs, Top 10 Lists, and more Results
Check out the latest on some of the Opioid Litigation, SPACS, and yes two Top 10 Lists!

Robin Bateman
Feb 27, 20222 min read


R&D Trends, ASCO-GU, & Earnings
The Eyes on Pharma team was caught up in reviewing global R&D trends and following the updates from ASCO-GU ...

Robin Bateman
Feb 22, 20222 min read
bottom of page
.png)